4
Changes in Ownership
Tarsus Pharmaceuticals, Inc. Filed Acc 0001788542-23-000002
Chief Commercial Officer sold 697 shares at an average $12.94 ($9,016)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Mottiwala Aziz Chief Commercial Officer | 2023-03-17 | Sale | −339 | $13.28 | $4,502 | 54,265 | D |
| Mottiwala Aziz Chief Commercial Officer | 2023-03-20 | Sale | −358 | $12.61 | $4,514 | 53,907 | D |
| Open-market sales · 697 sh · avg $12.94 · $9,016 | |||||||
Loading xslF345X04/wf-form4_167944011481271.xml…